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Photosensitivity associated with lupus erythematosus 
(LE) is well established. The photobiologic basis for this 
abnormal response to ultraviolet radiation, however, 
has not been determined. This paper summarizes the 
criteria for elucidating possible photobiologic mecha-
nisms and reviews the literature relevant to the mech-
anism of photosensitivity in LE. 
In patients with LE, photosensitivity to wavelengths 
shorter than 320 nm has been demonstrated; wave-
lengths longer than 320 nm have not been adequately 
evaluated. DNA is a possible chromophore for photosen-
sitivity below 320 nm. UV irradiation of skin produces 
thymine photodimers in DNA. UV-irradiated DNA is 
more antigenic than native DNA and the antigenicity of 
UV-irradiated DNA has been proposed, but not proven, 
to be involved in the development of clinical lesions. UV 
irradiation of mice previously injected with anti-UV-
DNA antibodies produces Ig deposition and complement 
fixation that appears to be similar to the changes seen 
in lupus lesions. Antibodies to UV -irradiated DNA occur 
in the serum of LE patients although a correlation be-
tween antibody titers and photosensitivity was not ob-
served. Defective repair of UV-induced DNA damage 
does not appear to be a mechanism for the photosensitiv-
ity in LE. Other mechanisms must also be considered. 
The chromophore for photosensitivity induced by wave-
lengths longer than 320 nm has not been investigated in 
vivo. In vitro studies indicate that 360-400 nm radia-
tion activates a photosensitizing compound in the lym-
phocytes and serum of LE patients and causes c.hromo-
somal aberrations and cell death. The mechamsm ap-
pears to involve superoxide anion. Further research is 
required to establish the action spectrum for lo.ng wave-
length photosensitivity in vivo and to elucidate the 
mechanisms for the photosensitivity at all wavelengths. 
Sunlight is well documented as a factor in the induction or 
exacerbation of lupus erythematosus (LE) [1- 3). In a large 
series of patients, 20-30% are often found by direct observa~io_n 
or by history to have a sun sensitivity. The characte~1stJc 
clinical lesions are often seen on the malar and other light-
exposed areas. Many investigators have demonstrated tha_t L~­
like skin lesions can be produced by exposure to art ificial 
sources of ultraviolet (UV) radiation. The role of UV radiation 
in the pathogenesis of LE remains uncertain. This topic has 
been reviewed recently by Morison [4). A particular exposure 
to UV radiation is associated with initiation of an eruption in 
only a small percentage of patients. It is much more common 
for sunlight exposure to exacerbate an existing eruption. The 
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systemic manifestations of the disease may also be aggravated 
by sunlight. 
In this paper the photobiologic processes involved in photo-
sensitivity in LE will be examined. The relevant vocabulary 
and concepts of photobiology will be summarized first and the 
criteria for understanding a photobiologic mechanism will be 
outlined. The literature on the photosensitivity associated with 
LE will be selectively rather than exhaustively reviewed and 
the experimental results will be related to possible photobio-
logic mechanisms. 
MECHANISMS IN PHOTOBIOLOGY 
Photobiologic events a re initiated by absorption of ultraviolet 
and visible radiat ion by molecules in the biologic system. The 
UV portion of the electromagnetic spectrum lies between 200 
and 400 nm and the visible portion between 400 and 800 nm. 
Ultraviolet radiation is often arbitrarily divided into UV A, 
UVB, and UVC. The UV A portion (320-400 nm) is not strongly 
absorbed by protein and nucleic acids and, while abundant in 
terrestrial sunlight, does not cause erythema in normal skin at 
moderate doses in the absence of photosensitizing chemicals. 
This range is also called "black light" and near-UV. UVB 
radiation (290-320 nm) is erythemogenic and present in the 
terrestrial solar spectrum. It is also referred to as sunburn 
radiation and mid-range UV. UVC radiation (200-290 nm) , 
(germicidal, far UV) is erythemogenic but does not reach the 
earth's surface. All 3 ultraviolet regions affect cells of the 
immune system in vivo and in vitro . Three recent books have 
reviewed the effects of nonionizing radiation on the immune 
system [5- 7). 
One or more specific chromophores (light-absorbing mole-
cules) are involved in each photobiologic response. After light 
absorption the chromophore undergoes chemical changes 
within its own structure or reacts with nearby molecules. Com-
plex biochemical processes ensue which culminate in cellular 
effects such as proliferation, mutagenesis, cell death , or alter-
ation in cell surface markers. The biologic result may not 
appear for hours or days after the exposure to UV radiation. In 
order to understand the mechanism for a photobiologic event, 
questions must be answered concerning: (1) the identity of the 
chromophore, (2) its photochemistry, (3) the ensuing biochem-
istry, and (4) the relationship between these processes and the 
observed biologic response. The chromophore may be an exog-
enous molecule such as a psoralen that causes cutaneous pho-
totoxicity, or an endogenous molecule such as a porphyrin that 
initiates the photosensitivity associated with porphyrias. Each 
chromophore is characterized by a unique absorption spectrum 
(a plot of the probability of absorption of light energy versus 
wavelength). The wavelengths that have the highest probability 
of absorption are called absorption maxima and are often used 
as identifying characteristics of a compound. 
Each photobiologic response has an associated action spec-
trum (a plot of the reciprocal of the number of incident photons 
required to produce a given effect versus wavelength) . Peaks in 
the action spectrum correspond to the most effective wave-
lengths . Determining action spectra is therefore a powerful tool 
for identification of putative chromophores since in an ideal 
case, the action spectrum corresponds to the absorption spec-
trum for the chromophore. Lack of correspondence between an 
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experimentally determined action spectrum and the absorption 
spectrum of the actual chromophore may occur due to com-
petitive absorption by other chromophores or other factors 
involving tissue optics. Consequently, one should exercise cau-
tion when attributing a photobiologic effect to a chromophore 
in the biologic system. The in vivo absorption spectrum of a 
chromophore may also differ from that in solution if the chro-
mophore associates with other molecules in the tissue. 
When an endogenous chromophore initiates a photobiologic 
response, elucidating the photobiologic mechanism also in-
cludes determining why the chromophore occurs in the diseased 
tissue compared to normal tissue or, if the chromophore is 
present in normal tissue, why the photobiologic response is 
observed only in diseased tissue. The precise environment of 
the chromophore must also be determined. Is it intercalated 
into DNA, associated with a certain subcellular structure, in 
plasma, etc.? 
Understanding the mechanism of a photobiologic event re-
quires knowledge of the photochemical reactions of the chro-
mophore that are responsible for initiating the biochemical 
response. Many chromophores are capable of more than one 
photochemical reaction depending on their location and their 
neighboring molecules. For example, DNA photoproducts in-
clude pyrimidine dimers, protein-DNA cross-links, and DNA 
chain cleavage. Photochemical studies are performed to deter-
mine the photoproducts of the reactions and the molecular 
mechanisms for formation of the products. Determining the 
biochemistry that connects the photochemical events with the 
observable biologic result is an active area of research. For 
example, the action spectrum for delayed erythema resembles 
the absorption spectrum of DNA indicating that DNA may be 
a chromophore. DNA is photochemically changed in vivo in 
human skin [8,9] . However, the inflammatory response of 
delayed erythema is due at least partially to prostaglandins 
(10]. The connection ( if any) between DNA photochemistry 
and prostaglandin formation is unknown . 
CHROMOPHORESRESPONSIDLEFOR 
PHOTOSENSITIVITY IN LE 
Many investigators have studied the abnormal response to 
UV radiation in patients with LE [1- 3, 11,12]. The wavelength 
dependence for production of skin lesions may suggest possible 
chromophores. UVC and UVB radiation appeared to be respon-
sible for elicitation of clinical LE-like lesions in many studies. 
Wavelengths longer than 320 nm from a hot quartz lamp were 
ineffective [2]. Longer wavelengths may sometimes elicit skin 
lesions, however. Freeman eta! [11] observed positive responses 
in 3 out of 6 patients using 330 nm radiation. Cripps and 
Rankin (12] produced erythema at 330 nm in 3 out of 6 
photosensitive LE patients. Negative results were obtained by 
Freeman et a! [11] with 340, 360, 400, and 500 nm radiation. 
However, the doses delivered to the skjn at these wavelengths 
may not have been sufficient since the same incident doses 
were used as those required at 300 nm to produce lesions. In 
general, the doses of UV A radiation are much greater than the 
doses of UVB radiation to achieve the same end point in normal 
skin. For example, UVA-induced erythema in normal skin in 
the absence of added photosensitizers requires about 1000 times 
as much incident energy as required for UVB-induced ery-
thema. Therefore the results of the study by Freeman eta! (ll] 
only indicate that the longer wavelengths were not as effective 
as 300 nm radiation. 
In patients photosensitivity to UV A radiation may be impor-
tant because terrestrial sunlight contains much more UV A than 
UVB radiation and therefore their daily exposure dose to UV A 
radiation is much greater. One report has appeared of photo-
sensitivity to fluorescent light from cool white tubes which emit 
little UVA and unmeasurable amounts of UVB [13] . The chro-
mophore for photobiologic responses to UVB and UVC radia-
tion is usually believed to be DNA. In tissue, DNA is a major 
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chromophore that absorbs UVB and UVC radiation. The data 
connecting DNA photochemistry to cutaneous lesions in LE is 
discussed below. For other photobiologic responses with action 
spectra extending over the UV A, UVB, and UVC ranges, the 
chromophore and mechanism are often different above and 
below 320 nm. These responses include mutagenesis and le-
thality to cells [14] and delayed tanning in human skin [15]. 
The same may be true for photosensitivity to different wave-
bands in LE. 
The chromophore responsible for photosensitivity in LE at 
wavelengths greater than 320 nm has received little attention. 
In one study in vitro, lymphocytes from LE patients were shown 
to be sensitive to 360-400 nm light as measured by decreased 
cell viability [16]. Normal cells were unaffected by the same 
light doses. The chromophore also appeared to be present in 
the serum of LE patients since 360-400 nm irradiation of 
normal lymphocytes with an ultrafiltrate of LE serum caused 
decreased cell viability. In both of these experiments mono-
chromatic light was used at 20 nm intervals between 300 and 
440 nm. The maximum effect was caused by 360, 380, and 400 
nm radiation. A correlation was not attempted, however, be-
tween presence of the photosensitizing factor in patients' serum 
and clinical photosensitivity to UV A. The molecular weight of 
the photosensitizer appeared to be between 2000 and 10,000 
daltons by ultrafiltration. No further characterization has ap-
peared of this possibly significant chromophore. 
In summary, it appears that photosensitive LE patients react 
to UVB and UVC radiation and that a possible chromophore 
in this wavelength range is DNA. In addition, some patients 
react to wavelengths greater than 320 nm. The chromophores 
for this response are not known but evidence has been pre-
sented indicating that LE serum contains a chromophore that 
photosensitizes cells to UV A radiation. 
PHOTOCHEMISTRY OF POSSIDLE CHROMOPHORES 
DNA must be considered as a possible chromophore for 
clinical responses to UVB and UVC radiation. The photochem-
istry of DNA has been extensively studied [17]. Cyclobutane 
pyrimidine photodimers are the major photoproducts when 
DNA is irradiated in vivo or in vitro with wavelengths less than 
320 nm. Other photoproducts such as pyrimidine-purine ad-
ducts [18] or 6-4 bipyrimidine adducts (19,20] may be biolog-
ically significant, even though they are formed at low yields. 
Possible pathways connecting the absorption of radiation by 
DNA to the clinical lesions are discussed later. One of the 
proposed pathways involves photochemical formation of anti-
genic determinants in DNA (called UV-DNA) upon UV irra-
diation. If the elicitation of cutaneous lesions involves UV-
DNA the major antigenic determinant is likely to be pyrimi-
dine ~hotodimers . They are formed upon irradiation of human 
skin in vivo with UVB [8,9]. In addition, it appears that even 
in polyclonal anti-UV-DNA Ab, thymine photodimers are ma-
jor antigenic determinants [21] . This conclusion was based on: 
(1) the ability to reverse the antigenicity with 235 nm radiation 
which produces pyrimidines from the dimers, (2) competition 
between UV -irradiated thymine-containing oligonucleotides 
and UV-DNA for antibody binding, and (3) the higher yield of 
antigenic UV-DNA from DNA with high thymine content. 
Therefore, if DNA is the chromophore for the photosensitivity 
at wavelengths Jess than 320 nm and the antigenicity of UV-
DNA is involved in the mechanism, circumstantial evidence 
indicates that the antigenic determinants are pyrimidine pho-
todimers. 
The photochemistry of the chromophore absorbing at 360-
400 nm has been briefly studied in vitro [16]. The photobiologic 
effects (cell killing and chromosomal aberrations) resulting 
from UV irradiation of normal lymphocytes in ultrafi!tered 
serum from LE patients appear to involve active oxygen species. 
The photosensitizing effect was abrogated when superoxide 
dis mutase was present during the irradiation of the cell suspen-
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sion or when t he purified factor was irradiated in the presence 
of superox ide dismutase a nd t hen filtered a nd added to cells. 
Therefore, superoxide an ion appears to be generated by a 
photochemica l reaction of the chromophore. The reaction may 
involve direct electron transfer from the photosensitizer to 
dissolved molecular oxygen or a more complex series of steps 
[22]. Superoxide a nion does not directly react with cellular 
molecules at s ignificant rates. Catalyzed decomposition of su-
peroxide a nion fo rms hydroxy radicals which rapidly react with 
protein , nucleic acids, and lipids. 
RELATIONSHIP OF PHOTOPRODUCTS TO 
CUTANEOUS LESIONS 
A pathway connecting in vivo formation of pyrimidine dimers 
and the photoinduced cutaneous lesions is consistent with some 
experimental data but data refuting th is pat hway have also 
been reported. The steps required for this pathway include: (1) 
UV -induced formation of pyrimidine photodimers in t issue, (2) 
exc ision of dimers from DNA by the excision repair pathway, 
(3) exit of the dimers from cell s to act as antigens for creation 
of a nti -UV-DNA Ab, a nd (4) subsequent exposure of the tissue 
to UVB radiation to form dimers t ha t are t hen released by 
DNA repair a nd bind to Ab at t he dermal -epidermal junction. 
Alternatively, Abare created to DNA which has been denatured 
by a non-UV process. These Ab cross-react with the small DNA 
fra gments conta ining dimers t hat a re released after UV irradia-
tion a nd repair. Both of these pathways require that the Ag/ 
Ab reaction occur at t he dermal -epidermal junction and that 
t his reaction he responsible for the appearance of clinica l 
lesions. The processes involved in producing clinical lesions 
from depos ition of immunoglobulin at the basement membrane 
are not understood. 
Evidence consistent with th is mecha ni sm includes t he follow -
ing. Irradiation of DNA produces UV -DNA, which is more 
a nti ge nic than native DNA. It is produced both in vitro and in 
vivo. For example, irradiation of human skin in vivo with either 
ge rmicidal (254 nm) or hot quartz (UVA-UVB) lamps produced 
mate ri al which reacted with a nti-UV-DNA Ab [23]. The action 
spectrum for UV -DNA formation in mouse skin included wave-
lengths from 254- 320 nm [24], as would be expected for a direct 
photochemica l reaction of DNA. Antinuclear antibodies in mice 
also could be produced by irradiation at 254 nm [25]. Further 
data indicating that DNA is a chromophore for the cutaneous 
lesions are that UVC irradiation of mice previously sensitized 
to UV -DNA resulted in fixation of mouse Ig and complement 
in t he dermal -epidermal junctions and in the nuclei of epider-
mal cell s by immunofluorescent studies [26]. These results were 
not found in mice treated on ly with irradiation or immuniza-
tion. Based on the s imilarity of these changes to those seen in 
lupus lesions, it appears that photosensitivity to wavelengths 
less than 320 nm in LE patients may involve anti -UV-DNA 
A b. 
Evidence against t hi s pathway includes the fact t hat irradia-
tion did not influence the fo rmation of antinuclear antibodies 
in NZB/W mice [27]. In addition, leve ls of anti-UV-DNA Ab 
in the se rum of LE patients did not correlate with the photo-
sensitivity of the patients [28] . 
Anti -UV -DNA Ab may not be t he major Ab involved in the 
immunologic process associated with UV photosensitivity in 
LE. U nidentitied photoproducts may be the actual source of 
the new antigenic determinants. Recent studies have shown 
that Ab to cytoplasmic antigens are found in LE patients and 
that these patients are photosensitive [29] . A recent s ignificant 
findin g is the UV -induced movement of cytoplasmic Ro antigen 
to t he cell surface [30] . Appearance of this antigen on t he cell 
surface would permit anti-Ro Ab to bind to the ce ll surface. 
Defective repa ir of UV-induced damage in LE is another 
potentia l pathway linking DNA photochemistry and clinical 
photosensitivi ty. However, the in vivo repair of pyrimidine 
dimers induced in t he DNA of skin of 9 LE patients was the 
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same as t hat observed in the skin of normal individuals [31]. 
Other pathways involving initial DNA photochemistry are 
also possible. For example, UV may induce expression of a gene 
and the new gene product may be antigenic. This postulated 
pathway also depends on a relationship between new antigens 
and clinical lesions, a mechanism that is sti ll obscure. 
The pathway between photochemistry induced by wave-
lengths greate r than 320 nm and clinical lesions in LE has not 
been investigated. If photosensitized cell killing by a chromo-
phore in LE tissue is s imilar to other cellular phototoxicity 
reactions, it is unlikely to produce Ig deposits at t he basement 
membrane. However, the DNA damage sensitized by these 
wavelengths in LE tissue may induce production of new anti-
gens as was hypothesized for irradiation at wavelengths less 
than 320 nm. 
In summary, the action spectrum for photosensitivity in LE 
includes UVB and UVC wavelength bands and probably ex-
tends into the UV A range. DNA is t he most probable chromo-
phore in t he UVC and UVB ranges. The chromophore respon-
sible for UV A photosensitivity is not known. The mechanism 
whereby photochemical reactions of the chromop hores initiate 
clinical les ions is not understood. Clearly, much research needs 
to be done in this area. 
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